Related Experiment Video
Updated: Mar 26, 2026

09:09
Foreign Accent and Forensic Speaker Identification in Voice Lineups: The Influence of Acoustic Features Based on Prosody
Published on: September 27, 2024
967
Clinical and acoustical variability in hypokinetic dysarthria
Journal of Communication Disorders
|October 1, 1986
Summary
This study on parkinsonism found that speech issues, or dysarthria, vary greatly between patients and are not strongly linked to disease severity. Understanding this variability is key to better characterizing hypokinetic dysarthria.
Area of Science:
- Neurology
- Speech-Language Pathology
- Neuroimaging
Background:
- Parkinsonism, including Parkinson's disease and progressive supranuclear palsy, often causes speech impairments known as hypokinetic dysarthria.
- Evaluating speech features and their relationship to neurological status is crucial for understanding these conditions.
Observation:
- Ten male patients with parkinsonism underwent clinical neurological, speech, and acoustical evaluations.
- Seven patients also received neuroimaging via computed tomography (CT) and (F-18)-fluorodeoxyglucose (FDG) positron emission tomography (PET).
- Significant variability was observed in both clinical and acoustical speech features among patients.
Findings:
- Speech feature variability was largely independent of parkinsonian sign severity, CT, or FDG PET findings.
- Little correlation was found between different measured speech features.
- The overall severity of dysarthria appeared to be the primary factor influencing abnormal acoustic measures.
Implications:
- Further research into patient-to-patient variability in speech is recommended for a comprehensive understanding of hypokinetic dysarthria.
- Focusing on isolated speech features, like speaking rate, may oversimplify the complex nature of hypokinetic dysarthria.
- Recognizing the extensive variability is essential for accurate diagnosis and targeted therapeutic strategies in parkinsonism-related speech disorders.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
732
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
732
Larynx
6.1K
The human larynx, often referred to as the voice box, is an intricate organ located in the neck. It serves as a pathway for air to enter the lungs during respiration and is an essential component of voice production.
Anatomy of the Larynx
The larynx consists of various components, including cartilage, muscles, and vocal cords. Its structure includes three large unpaired cartilages—the thyroid, cricoid, and epiglottis—and three smaller paired cartilages—the arytenoids,...
Anatomy of the Larynx
The larynx consists of various components, including cartilage, muscles, and vocal cords. Its structure includes three large unpaired cartilages—the thyroid, cricoid, and epiglottis—and three smaller paired cartilages—the arytenoids,...
6.1K
Variability: Analysis
623
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
The range is a simple measure of variability, indicating the difference between the highest and...
623
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K

